![IJMS | Free Full-Text | Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages IJMS | Free Full-Text | Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages](https://pub.mdpi-res.com/ijms/ijms-24-09641/article_deploy/html/images/ijms-24-09641-ag.png?1686103425)
IJMS | Free Full-Text | Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages
![These highlights do not include all the information needed to use TREXALL® safely and effectively. See full prescribing information for TREXALL. TREXALL® (methotrexate tablets), for oral use Initial U.S. Approval: 1953 These highlights do not include all the information needed to use TREXALL® safely and effectively. See full prescribing information for TREXALL. TREXALL® (methotrexate tablets), for oral use Initial U.S. Approval: 1953](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-4.jpg&id=659159)
These highlights do not include all the information needed to use TREXALL® safely and effectively. See full prescribing information for TREXALL. TREXALL® (methotrexate tablets), for oral use Initial U.S. Approval: 1953
![These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953 These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-2.jpg&id=659365)
These highlights do not include all the information needed to use METHOTREXATE TABLETS safely and effectively. See full prescribing information for METHOTREXATE TABLETS. METHOTREXATE tablets, for oral use Initial U.S. Approval: 1953
![Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 10 mL Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 10 mL](https://www.suprememed.com/wp-content/uploads/2022/02/antineoplasticagentmethotrexatesodiumpreservativefree25mgmlinjtev00703367103ct10-595x595.jpg)
Antineoplastic Agent Methotrexate Sodium, Preservative Free 25 mg / mL Injection Single Dose Vial 10 mL
ChemoClave™ Closed System Transfer Device (CSTD) Surface Wipe Study Using Methotrexate (MTX) as a Marker
![Press Release: Oregon And 43 States Sue Teva Pharmaceuticals Over Price Fixing for Generic Drugs | The Lund Report Press Release: Oregon And 43 States Sue Teva Pharmaceuticals Over Price Fixing for Generic Drugs | The Lund Report](https://www.thelundreport.org/sites/default/files/styles/wide/public/article-images/Attorney%20General%20Ellen%20Rosenblum.jpg?itok=moOjqUww)